While B-type natriuretic peptide (BNP) levels remain high in patients with end-stage heart failure with cardiogenic shock, these levels lose their prognostic value in patients using ventricular assist ...

BNP levels in the blood reflects the severity of cardiac dysfunction. Higher BNP levels have been associated with adverse clinical outcomes. This study looked at end-stage heart failure patients with ...

Please provide your email address to receive an email when new articles are posted on . Addition of soluble urokinase-type plasminogen activator receptor levels to models including B-type natriuretic ...

Brain natriuretic peptide (BNP), a substance secreted by the heart that is associated with congestive heart failure and renal failure, does not predict reduction in systolic blood pressure (BP) in ...

Among patients at risk of heart failure, collaborative care based on screening for certain levels of brain-type natriuretic peptide reduced the combined rates of left ventricular systolic dysfunction, ...

The relationship between cardiovascular dysfunction and renal impairment is widely recognized as the cardiorenal interaction, a complex physiological link in which damage to one organ can accelerate ...

B-type natriuretic peptide shows a graded association with decline in kidney function in individuals with diabetes, even at concentrations ≤ 18.4 pg/mL, which are conventionally considered normal.

Dr. Pankaj Arora, MD, FAHA, is a physician scientist in the Division of Cardiovascular Disease with expertise in the human genetics and genomics of complex cardiovascular traits, as well as ...

Diastolic heart failure is common in the elderly, particularly women. Previous studies on the value of brain natriuretic peptide in diastolic dysfunction have been largely limited to male subjects.

A scientific statement regarding the evaluation and management of pediatric patients with ADHF has been published by the AHA.